← Leaderboards
Sunwen Chou
Portland Va Research Foundation, Inc.
$6,414,113
Attributed
$6,414,113
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $346.5K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,414,113 · 5
VA$0 · 1
By mechanism
R01$5,895,202 · 2
R56$315,000 · 1
M01$172,411 · 1
R03$31,500 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusDrug ResistanceCidofovirFoscarnetGanciclovirAntiviral AgentsMutationViralPharmaceutical PreparationsToxic EffectGeneticDiagnosisMaribavirResistanceImmunocompromised HostOralDna-Directed Dna PolymeraseResistance MutationKinase InhibitorAntiviral TherapyTransplant RecipientsPhenotypePhosphotransferasesDesign
Grant awards (30)
Genetic Pathways of Human Cytomegalovirus Drug Resistance$312,000
R01 · FY2025 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$312,000
R01 · FY2024 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$312,000
R01 · FY2023 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$130,000
R01 · FY2022 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$315,000
R56 · FY2021 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$315,000
R01 · FY2019 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$315,000
R01 · FY2018 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$315,000
R01 · FY2017 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$315,000
R01 · FY2016 · AI · contact PI
Genetic Pathways of Human Cytomegalovirus Drug Resistance$157,500
R01 · FY2015 · AI · contact PI
Alternative antiviral drug targets for human cytomegalovirus infection$0
I01 · FY2014 · VA · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$261,188
R01 · FY2013 · AI · contact PI
Alternative antiviral drug targets for human cytomegalovirus infection$0
I01 · FY2013 · VA · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$339,605
R01 · FY2012 · AI · contact PI
Alternative antiviral drug targets for human cytomegalovirus infection$0
I01 · FY2012 · VA · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$339,605
R01 · FY2011 · AI · contact PI
Alternative antiviral drug targets for human cytomegalovirus infection$0
I01 · FY2011 · VA · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$343,035
R01 · FY2010 · AI · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$346,500
R01 · FY2009 · AI · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$238,941
R01 · FY2007 · AI · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$246,078
R01 · FY2006 · AI · contact PI
Antiviral Drug Resistance in Human Cytomegalovirus$252,000
R01 · FY2005 · AI
Antiviral Drug Resistance in Human Cytomegalovirus$252,000
R01 · FY2004 · AI
Antiviral Drug Resistance in Human Cytomegalovirus$264,250
R01 · FY2003 · AI
Antiviral Drug Resistance in Human Cytomegalovirus$264,250
R01 · FY2002 · AI
Antiviral Drug Resistance in Human Cytomegalovirus$264,250
R01 · FY2001 · AI
Cellular immunity to HCV infection following liver transplantation$172,411
M01 · FY2001 · RR
Cellular immunity to HCV infection following liver transplantation$0
M01 · FY2001 · RR
DRUG RESISTANCE IN HUMAN CYTOMEGALOVIRUS$31,500
R03 · FY2000 · TW
Cellular immunity to HCV infection following liver transplantation$0
M01 · FY2000 · RR